Table 2 Mortality in patients who survived from sepsis with and without SLE
From: Impact of systemic lupus erythematosus on the 5-year survival of critically ill septic patients
|  | Total | Event (%) | Total person-years | Incidence rate (/105 years) | Crude IRR (95%CI) |
|---|---|---|---|---|---|
6-month mortality | |||||
 SLE | 513 | 264 (51.5%) | 154 | 171,287 | 2.62 (2.3–3.0) |
 Non-SLE | 2052 | 517 (25.2%) | 792 | 65,313 | 1 |
1-year mortality | |||||
 SLE | 513 | 292 (56.9%) | 267 | 109,410 | 2.66 (2.3–3.1) |
 Non-SLE | 2052 | 608 (29.6%) | 1476 | 41,188 | 1 |
5-year mortality | |||||
 SLE | 513 | 363 (70.8%) | 942 | 38,516 | 2.8 (2.5–3.2) |
 Non-SLE | 2052 | 827 (40.3%) | 6045 | 13,680 | 1 |